Evidence map›Paper›PMID 29383144›Full record

ArticleOncotarget2017

Insufficient microwave ablation-induced promotion of distant metastasis is suppressed by β-catenin pathway inhibition in breast cancer.

Peng Kong, Hong Pan, Muxin Yu, Lie Chen, Han Ge, Jin Zhu, Ge Ma, Li Li, Qiang Ding, Wenbin Zhou and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Peng Kong *Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Hong Pan *Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Muxin Yu *Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Lie ChenDepartment of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Han GeDepartment of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Jin ZhuDepartment of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Ge MaDepartment of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Li LiDepartment of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Qiang DingDepartment of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Wenbin ZhouDepartment of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Shui WangDepartment of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, 210029 Nanjing, China.
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microwave ablation (MWA), a thermal ablation, is an effective treatment for breast cancer. However, residual breast cancer is still detected. The biological characteristics of residual breast cancer after thermal ablation remain unknown. To mimic insufficient MWA

Indexed as

breast cancerepithelial-mesenchymal transition (EMT)metastasismicrowave ablationβ-catenin

Identifiers

PMID29383144
PMCPMC5777756
OpenAlexW2771592604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.